XML 115 R99.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity - Market-Based Stock Options (Details) - Market Based Stock Options - USD ($)
 12 Months Ended
Dec. 07, 2021
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Stock-based compensation          
Share price   $ 14      
Threshold period of specified consecutive trading days within which common stock price to be trade to vest stock options   20 days      
Minimum percentage of closing price of the Company's common stock on the market-based stock option grant date   207.00%      
Contractual term   10 years      
Number of Shares          
Outstanding at the beginning of the period (in shares)   3,650,000      
Granted (in shares)   0 0 0 3,700,000
Exercised (in shares)   0      
Forfeited or expired (in shares)   0      
Outstanding at the end of the period (in shares)   3,650,000 3,650,000    
Exercisable at the end of the period (in shares)   0      
Weighted Average Exercise Price          
Outstanding at the beginning of the period (in dollars per share)   $ 6.77      
Granted (in dollars per share)   0      
Exercised (in dollars per share)   0      
Forfeited or expired (in dollars per share)   6.77      
Outstanding at the end of the period (in dollars per share)   6.77 $ 6.77    
Exercisable at the end of the period (in dollars per share)   $ 0      
Additional option disclosures          
Outstanding at the end of the period, weighted average remaining contractual term   6 years 11 months 8 days      
Exercisable at the end of the period, weighted average remaining contractual term   0 years      
Outstanding at the end of the period, aggregate intrinsic value   $ 0      
Exercisable at the end of the period, aggregate intrinsic value   0      
Total unrecognized compensation cost related to non-vested shares   $ 0      
Unrecognized compensation cost, weighted-average period   2 years      
Total fair value of shares vested   $ 0      
Weighted-average assumption used for grants          
Dividend yield 0.00%        
Expected volatility 67.80%        
Risk-free interest rate 1.50%        
Expected life 10 years        
Stock-based compensation          
Weighted-average grant date fair values of options granted (in dollars per share)         $ 4.87
Exercised during the period, aggregate intrinsic value   0 $ 0 $ 0  
Stock-based compensation expense   $ 0 $ 8,200,000 $ 9,400,000